Recursion Pharmaceuticals
RXRX
RXRX
126 hedge funds and large institutions have $1.62B invested in Recursion Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 52 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
50% more funds holding
Funds holding: 84 → 126 (+42)
28% more capital invested
Capital invested by funds: $1.26B → $1.62B (+$352M)
24.61% more ownership
Funds ownership: 34.53% → 59.14% (+25%)
Holders
126
Holding in Top 10
8
Calls
$2.03M
Puts
$878K
Top Buyers
| 1 | +$85.6M | |
| 2 | +$58.3M | |
| 3 | +$51.6M | |
| 4 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
+$21.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$21.2M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$12.6M | |
| 3 | -$8.68M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.36M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$6.2M |